Caricamento...
Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma
BACKGROUND: Conjunctival melanoma is a potentially lethal malignancy of the ocular surface. There have been no therapeutic advancements made in the past several decades despite increasing prevalence of the disease. METHODS: The authors report the case of a 52-year-old Caucasian male with unresectabl...
Salvato in:
| Pubblicato in: | Ocul Oncol Pathol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
S. Karger AG
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984155/ https://ncbi.nlm.nih.gov/pubmed/32002403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000497473 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|